missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SIVA1 (aa 95-151) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (68%), Rat (68%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-66860 (PA5-66860. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Induces CD27-mediated apoptosis. Inhibits BCL2L1 isoform Bcl-x(L) anti-apoptotic activity. Inhibits activation of NF-kappa-B and promotes T-cell receptor-mediated apoptosis.
Specifications
Specifications
| Accession Number | O15304 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 10572 |
| Name | Human SIVA1 (aa 95-151) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | apoptosis regulatory protein Siva; Cd27 binding protein; CD27-binding (Siva) protein; CD27-binding protein; CD27BP; SIVA; SIVA1; Siva-1; SIVA1 apoptosis inducing factor; SIVA1, apoptosis-inducing factor; Siva-2 |
| Common Name | SIVA1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction